Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes

Diabetes Care. 2005 Mar;28(3):754-5. doi: 10.2337/diacare.28.3.754.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adiponectin
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Atorvastatin
  • C-Reactive Protein / metabolism
  • Cytokines / blood*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / immunology*
  • Female
  • Heptanoic Acids / therapeutic use*
  • Hormones, Ectopic / blood
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Leptin / blood
  • Male
  • Placebos
  • Pyrroles / therapeutic use*
  • Resistin

Substances

  • Adiponectin
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Heptanoic Acids
  • Hormones, Ectopic
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Placebos
  • Pyrroles
  • RETN protein, human
  • Resistin
  • C-Reactive Protein
  • Atorvastatin